AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/113
PEPTIDE VACCINATION WITH AN ANCHOR-REPLACED CTL EPITOPE PROTECTS AGAINST HUMAN-PAPILLOMAVIRUS TYPE 16-INDUCED TUMORS EXPRESSING THE WILD-TYPE EPITOPE
Authors: VIERBOOM MPM FELTKAMP MCW NEISIG A DRIJFHOUT JW TERSCHEGGET J NEEFJES JJ MELIEF CJM KAST WM
Citation: Mpm. Vierboom et al., PEPTIDE VACCINATION WITH AN ANCHOR-REPLACED CTL EPITOPE PROTECTS AGAINST HUMAN-PAPILLOMAVIRUS TYPE 16-INDUCED TUMORS EXPRESSING THE WILD-TYPE EPITOPE, Journal of immunotherapy, 21(6), 1998, pp. 399-408
T-CELL IMMUNITY AGAINST TUMORS, A DELICATE BALANCING ACT INVOLVING DENDRITIC CELLS
Authors: MELIEF CJM
Citation: Cjm. Melief, T-CELL IMMUNITY AGAINST TUMORS, A DELICATE BALANCING ACT INVOLVING DENDRITIC CELLS, Annals of oncology, 9, 1998, pp. 23-23
INFECTION OF HUMAN DENDRITIC CELL WITH RECOMBINANT ADENOVIRUSES ENHANCES THEIR ANTIGEN-PRESENTING FUNCTION
Authors: REA D HOEBEN R TOES REM VANDEREB AJ MELIEF CJM OFFRINGA R
Citation: D. Rea et al., INFECTION OF HUMAN DENDRITIC CELL WITH RECOMBINANT ADENOVIRUSES ENHANCES THEIR ANTIGEN-PRESENTING FUNCTION, Journal of leukocyte biology, 1998, pp. 61-61
T-CELL IMMUNITY AGAINST TUMORS - A DELICATE BALANCING ACT
Authors: MELIEF CJM
Citation: Cjm. Melief, T-CELL IMMUNITY AGAINST TUMORS - A DELICATE BALANCING ACT, Pathologie et biologie, 46(2), 1998, pp. 127-127
L1-SPECIFIC PROTECTION FROM TUMOR CHALLENGE ELICITED BY HPV16 VIRUS-LIKE PARTICLES
Authors: DEBRUIJN MLH GREENSTONE HL VERMEULEN H MELIEF CJM LOWY DR SCHILLER JT KAST WM
Citation: Mlh. Debruijn et al., L1-SPECIFIC PROTECTION FROM TUMOR CHALLENGE ELICITED BY HPV16 VIRUS-LIKE PARTICLES, Virology (New York, N.Y. Print), 250(2), 1998, pp. 371-376
T-CELL HELP FOR CYTOTOXIC T-LYMPHOCYTES IS MEDIATED BY CD40-CD40L INTERACTIONS
Authors: SCHOENBERGER SP TOES REM VANDERVOORT EIH OFFRINGA R MELIEF CJM
Citation: Sp. Schoenberger et al., T-CELL HELP FOR CYTOTOXIC T-LYMPHOCYTES IS MEDIATED BY CD40-CD40L INTERACTIONS, Nature, 393(6684), 1998, pp. 480-483
CUTTING EDGE - CROSS-PRIMING OF CTL RESPONSES IN-VIVO DOES NOT REQUIRE ANTIGENIC PEPTIDES IN THE ENDOPLASMIC-RETICULUM OF IMMUNIZING CELLS
Authors: SCHOENBERGER SP VANDERVOORT EIH KRIETEMEIJER GM OFFRINGA R MELIEF CJM TOES REM
Citation: Sp. Schoenberger et al., CUTTING EDGE - CROSS-PRIMING OF CTL RESPONSES IN-VIVO DOES NOT REQUIRE ANTIGENIC PEPTIDES IN THE ENDOPLASMIC-RETICULUM OF IMMUNIZING CELLS, The Journal of immunology (1950), 161(8), 1998, pp. 3808-3812
ENHANCEMENT OF TUMOR OUTGROWTH THROUGH CTL TOLERIZATION AFTER PEPTIDEVACCINATION IS AVOIDED BY PEPTIDE PRESENTATION ON DENDRITIC CELLS
Authors: TOES REM VANDERVOORT EIH SCHOENBERGER SP DRIJFHOUT JW VANBLOOIS L STORM G KAST WM OFFRINGA R MELIEF CJM
Citation: Rem. Toes et al., ENHANCEMENT OF TUMOR OUTGROWTH THROUGH CTL TOLERIZATION AFTER PEPTIDEVACCINATION IS AVOIDED BY PEPTIDE PRESENTATION ON DENDRITIC CELLS, The Journal of immunology, 160(9), 1998, pp. 4449-4456
REDUCED CELL-SURFACE EXPRESSION OF HLA-C MOLECULES CORRELATES WITH RESTRICTED PEPTIDE BINDING AND STABLE TAP INTERACTION
Authors: NEISIG A MELIEF CJM NEEFJES J
Citation: A. Neisig et al., REDUCED CELL-SURFACE EXPRESSION OF HLA-C MOLECULES CORRELATES WITH RESTRICTED PEPTIDE BINDING AND STABLE TAP INTERACTION, The Journal of immunology, 160(1), 1998, pp. 171-179
CHARACTERIZATION OF HLA-B57-RESTRICTED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG-SPECIFIC AND RT-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES
Authors: KLEIN MR VANDERBURG SH HOVENKAMP E HOLWERDA AM DRIJFHOUT JW MELIEF CJM MIEDEMA F
Citation: Mr. Klein et al., CHARACTERIZATION OF HLA-B57-RESTRICTED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG-SPECIFIC AND RT-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES, Journal of General Virology, 79, 1998, pp. 2191-2201
SPECIFIC T-HELPER CELL REQUIREMENT FOR OPTIMAL INDUCTION OF CYTOTOXICT-LYMPHOCYTES AGAINST MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II NEGATIVE TUMORS
Authors: OSSENDORP F MENGEDE E CAMPS M FILIUS R MELIEF CJM
Citation: F. Ossendorp et al., SPECIFIC T-HELPER CELL REQUIREMENT FOR OPTIMAL INDUCTION OF CYTOTOXICT-LYMPHOCYTES AGAINST MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II NEGATIVE TUMORS, The Journal of experimental medicine, 187(5), 1998, pp. 693-702
IMMUNIZATION WITH HUMAN-PAPILLOMAVIRUS TYPE-16 (HPV16) ONCOPROTEIN-LOADED DENDRITIC CELLS AS WELL AS PROTEIN IN ADJUVANT INDUCES MHC CLASS I-RESTRICTED PROTECTION TO HPV16-INDUCED TUMOR-CELLS
Authors: DEBRUIJN MLH SCHUURHUIS DH VIERBOOM MPM VERMEULEN H DECOCK KAJ OOMS ME RESSING ME TOEBES M FRANKEN KLMC DRIJFHOUT JW OTTENHOFF THM OFFRINGA R MELIEF CJM
Citation: Mlh. Debruijn et al., IMMUNIZATION WITH HUMAN-PAPILLOMAVIRUS TYPE-16 (HPV16) ONCOPROTEIN-LOADED DENDRITIC CELLS AS WELL AS PROTEIN IN ADJUVANT INDUCES MHC CLASS I-RESTRICTED PROTECTION TO HPV16-INDUCED TUMOR-CELLS, Cancer research, 58(4), 1998, pp. 724-731
CRYPTIC OPEN READING FRAMES IN PLASMID VECTOR BACKBONE SEQUENCES CAN PROVIDE HIGHLY IMMUNOGENIC CYTOTOXIC T-LYMPHOCYTE EPITOPES
Authors: VANHALL T VANDERHEE NE SCHOENBERGER SP VIERBOOM MPM VERRECK FAW MELIEF CJM OFFRINGA R
Citation: T. Vanhall et al., CRYPTIC OPEN READING FRAMES IN PLASMID VECTOR BACKBONE SEQUENCES CAN PROVIDE HIGHLY IMMUNOGENIC CYTOTOXIC T-LYMPHOCYTE EPITOPES, Cancer research, 58(14), 1998, pp. 3087-3093
EFFICIENT DIRECT PRIMING OF TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTE IN-VIVO BY AN ENGINEERED APC
Authors: SCHOENBERGER SP JONGES LE MOOIJAART RJD HARTGERS F TOES REM KAST WM MELIEF CJM OFFRINGA R
Citation: Sp. Schoenberger et al., EFFICIENT DIRECT PRIMING OF TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTE IN-VIVO BY AN ENGINEERED APC, Cancer research, 58(14), 1998, pp. 3094-3100
BCR-ABL PEPTIDES CAN BIND TO A VARIETY OF MHC CLASS-I MOLECULES
Authors: KESSLER JH HUIJBERS IJG TENBOSCH GJA BRESVLOEMANS AA BENCKHUIJSEN W DRIJFHOUT JW MELIEF CJM LEEKSMA OC
Citation: Jh. Kessler et al., BCR-ABL PEPTIDES CAN BIND TO A VARIETY OF MHC CLASS-I MOLECULES, British Journal of Haematology, 102(1), 1998, pp. 83-83
BCR-ABL ONCOPROTEIN EXPRESSION IN PLATELETS FROM CML PATIENTS IS ASSOCIATED WITH CRKL PHOSPHORYLATION
Authors: TENBOSCH GJA KESSLER JH BLOM J JOOSTEN AM MELIEF CJM LEEKSMA OC
Citation: Gja. Tenbosch et al., BCR-ABL ONCOPROTEIN EXPRESSION IN PLATELETS FROM CML PATIENTS IS ASSOCIATED WITH CRKL PHOSPHORYLATION, British Journal of Haematology, 102(1), 1998, pp. 181-181
EFFECTS OF THROMBOPOIETIN ON THE PROLIFERATION AND DIFFERENTIATION OFPRIMITIVE AND MATURE HEMATOPOIETIC PROGENITOR CELLS IN CORD-BLOOD
Authors: SCHIPPER LF BRAND A RENIERS NCM MELIEF CJM WILLEMZE R FIBBE WE
Citation: Lf. Schipper et al., EFFECTS OF THROMBOPOIETIN ON THE PROLIFERATION AND DIFFERENTIATION OFPRIMITIVE AND MATURE HEMATOPOIETIC PROGENITOR CELLS IN CORD-BLOOD, British Journal of Haematology, 101(3), 1998, pp. 425-435
CD80-TRANSFECTED ACUTE MYELOID-LEUKEMIA CELLS INDUCE PRIMARY ALLOGENEIC T-CELL RESPONSES DIRECTED AT PATIENT-SPECIFIC MINOR HISTOCOMPATIBILITY ANTIGENS AND LEUKEMIA-ASSOCIATED ANTIGENS
Authors: MUTIS T SCHRAMA E MELIEF CJM GOULMY E
Citation: T. Mutis et al., CD80-TRANSFECTED ACUTE MYELOID-LEUKEMIA CELLS INDUCE PRIMARY ALLOGENEIC T-CELL RESPONSES DIRECTED AT PATIENT-SPECIFIC MINOR HISTOCOMPATIBILITY ANTIGENS AND LEUKEMIA-ASSOCIATED ANTIGENS, Blood, 92(5), 1998, pp. 1677-1684
PRECLINICAL AND CLINICAL-EXPERIENCE WITH PEPTIDE-BASED VACCINES AGAINST HPV16-INDUCED TUMORS
Authors: MELIEF CJM
Citation: Cjm. Melief, PRECLINICAL AND CLINICAL-EXPERIENCE WITH PEPTIDE-BASED VACCINES AGAINST HPV16-INDUCED TUMORS, European journal of cancer, 33, 1997, pp. 1301-1301
AUTOANTIBODIES TO P53 IN OVARIAN-CANCER PATIENTS AND HEALTHY WOMEN - A COMPARISON BETWEEN WHOLE P53 PROTEIN AND 18-MER PEPTIDES FOR SCREENING PURPOSES
Authors: VENNEGOOR CJGM NIJMAN HW DRIJFHOUT JW VERNIE L VERSTRAETEN RA VONMENSDORFFPOUILLY S HILGERS J VERHEIJEN RHM KAST WM MELIEF CJM KENEMANS P
Citation: Cjgm. Vennegoor et al., AUTOANTIBODIES TO P53 IN OVARIAN-CANCER PATIENTS AND HEALTHY WOMEN - A COMPARISON BETWEEN WHOLE P53 PROTEIN AND 18-MER PEPTIDES FOR SCREENING PURPOSES, Cancer letters, 116(1), 1997, pp. 93-101
IDENTIFICATION OF POTENTIAL HLA-A-ASTERISK-0201 RESTRICTED CTL EPITOPES DERIVED FROM THE EPITHELIAL-CELL ADHESION MOLECULE (EP-CAM) AND THECARCINOEMBRYONIC ANTIGEN (CEA)
Authors: RAS E VANDERBURG SH ZEGVELD ST BRANDT RMP KUPPEN PJK OFFRINGA R WARNARR SO VANDEVELDE CJH MELIEF CJM
Citation: E. Ras et al., IDENTIFICATION OF POTENTIAL HLA-A-ASTERISK-0201 RESTRICTED CTL EPITOPES DERIVED FROM THE EPITHELIAL-CELL ADHESION MOLECULE (EP-CAM) AND THECARCINOEMBRYONIC ANTIGEN (CEA), Human immunology, 53(1), 1997, pp. 81-89
DO EPITOPES DERIVED FROM AUTOANTIGENS DISPLAY LOW-AFFINITY FOR MHC CLASS-I
Authors: VANDERBURG SH VISSEREN MJW OFFRINGA R MELIEF CJM
Citation: Sh. Vanderburg et al., DO EPITOPES DERIVED FROM AUTOANTIGENS DISPLAY LOW-AFFINITY FOR MHC CLASS-I, Immunology today, 18(2), 1997, pp. 97-98
PROTECTIVE ANTITUMOR IMMUNITY INDUCED BY VACCINATION WITH RECOMBINANTADENOVIRUSES ENCODING MULTIPLE TUMOR-ASSOCIATED CYTOTOXIC T-LYMPHOCYTE EPITOPES IN A STRING-OF-BEADS FASHION
Authors: TOES REM HOEBEN RC VANDERVOORT EIH RESSING ME VANDEREB AJ MELIEF CJM OFFRINGA R
Citation: Rem. Toes et al., PROTECTIVE ANTITUMOR IMMUNITY INDUCED BY VACCINATION WITH RECOMBINANTADENOVIRUSES ENCODING MULTIPLE TUMOR-ASSOCIATED CYTOTOXIC T-LYMPHOCYTE EPITOPES IN A STRING-OF-BEADS FASHION, Proceedings of the National Academy of Sciences of the United Statesof America, 94(26), 1997, pp. 14660-14665
HIV-1 REVERSE TRANSCRIPTASE-SPECIFIC CTL AGAINST CONSERVED EPITOPES DO NOT PROTECT AGAINST PROGRESSION TO AIDS
Authors: VANDERBURG SH KLEIN MR PONTESILLI O HOLWERDA AM DRIJFHOUT JW KAST WM MIEDEMA F MELIEF CJM
Citation: Sh. Vanderburg et al., HIV-1 REVERSE TRANSCRIPTASE-SPECIFIC CTL AGAINST CONSERVED EPITOPES DO NOT PROTECT AGAINST PROGRESSION TO AIDS, The Journal of immunology, 159(7), 1997, pp. 3648-3654
TARGETING OF CYTOTOXIC T-CELLS AGAINST LEUKEMIC B-CELLS BY BISPECIFICANTIBODY (ACD3 X ACD19) DOES NOT DISTRACT THE T-CELL FROM ITS PRIMARYTARGET
Authors: KLEIN SC VANDERBURG SH BOER LH MELIEF CJM KAST WM DEGAST GC BAST EJEG
Citation: Sc. Klein et al., TARGETING OF CYTOTOXIC T-CELLS AGAINST LEUKEMIC B-CELLS BY BISPECIFICANTIBODY (ACD3 X ACD19) DOES NOT DISTRACT THE T-CELL FROM ITS PRIMARYTARGET, The Journal of immunology, 159(11), 1997, pp. 5545-5549
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>